These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6255734)

  • 21. [Prevention of poliomyelitis: live or killed vaccine? Remarks apropos of 2 cases of poliomyelitis].
    Bergouignan FX; Saintarailles J; Roux D; Guillon J; Bonnici JF; Fleury H; Henry P
    Presse Med; 1984 Oct; 13(37):2241-3. PubMed ID: 6095246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The final phase of polio eradication: new vaccines and complex choices.
    Cochi SL; Linkins RW
    J Infect Dis; 2012 Jan; 205(2):169-71. PubMed ID: 22158681
    [No Abstract]   [Full Text] [Related]  

  • 23. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
    Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
    J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
    Viktorova EG; Khattar SK; Kouiavskaia D; Laassri M; Zagorodnyaya T; Dragunsky E; Samal S; Chumakov K; Belov GA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine-related poliomyelitis: serum IgM and cerebrospinal fluid antibodies.
    Openshaw H; Lieberman JS
    West J Med; 1983 Mar; 138(3):420-2. PubMed ID: 6305036
    [No Abstract]   [Full Text] [Related]  

  • 26. Is poliomyelitis in the tropics provoked by injections?
    Wyatt HV
    Afr J Med Med Sci; 1980; 9(1-2):73-80. PubMed ID: 6282092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine.
    Peng X; Hu X; Salazar MA
    Lancet; 2018 Aug; 392(10147):610-612. PubMed ID: 29605427
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The replacement of poliomyelitis by vaccine-associated poliomyelitis].
    Arlazoroff A
    Harefuah; 1987 Dec; 113(12):415-6. PubMed ID: 3452586
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter: Poliomyelitis after contact with recently vaccinated infant.
    Wilson J; Robinson R
    Br Med J; 1974 Apr; 2(5909):53. PubMed ID: 4362453
    [No Abstract]   [Full Text] [Related]  

  • 31. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines.
    McBean AM; Thoms ML; Albrecht P; Cuthie JC; Bernier R
    Am J Epidemiol; 1988 Sep; 128(3):615-28. PubMed ID: 2843039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Poliomyelitis associated with a vaccine: 2 clinical cases].
    González E; Cordero J
    Rev Med Chil; 1988 May; 116(5):461-4. PubMed ID: 2854294
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies.
    Minor P
    Dev Biol (Basel); 2001; 105():75-80. PubMed ID: 11763340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.
    Ramsay ME; Begg NT; Gandhi J; Brown D
    Pediatr Infect Dis J; 1994 Dec; 13(12):1117-21. PubMed ID: 7892081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fractional doses of inactivated poliovirus vaccine in Oman.
    Mohammed AJ; AlAwaidy S; Bawikar S; Kurup PJ; Elamir E; Shaban MM; Sharif SM; van der Avoort HG; Pallansch MA; Malankar P; Burton A; Sreevatsava M; Sutter RW
    N Engl J Med; 2010 Jun; 362(25):2351-9. PubMed ID: 20573923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two cases of vaccine-induced poliomyelitis.
    Mertens T; Schürmann W; Kruppenbacher JP; Eggers HJ; Rheingans K; Kellermann K; Leidel J
    Acta Paediatr Scand; 1984 Jan; 73(1):133-4. PubMed ID: 6322508
    [No Abstract]   [Full Text] [Related]  

  • 38. [Humoral antibodies, coproantibodies and viral excretion in newborn infants immunized with poliomyelitis vaccine].
    Ruíz-Gómez J; Caloca García MA; Longega Escobio P
    Salud Publica Mex; 1979; 21(2):127-34. PubMed ID: 231330
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccine-associated paralytic poliomyelitis in the Russian Federation in 1998-2014.
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Korotkova EA; Kozlovskaya LI; Baykova OY; Krasota AY; Gmyl AP
    Int J Infect Dis; 2018 Nov; 76():64-69. PubMed ID: 30201507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poliomyelitis vaccines in Belgium: 20 years of experience.
    Andre FE
    Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.